Abstract: An approach is provided that receives a set of actual hardware power consumption details and a set of software activity details with all of the details pertaining to the use of a computer system at a first time. Based on the set of software activity details, the approach determines a set of expected hardware power consumption details. The set of actual hardware power consumption details are compared to the set of expected hardware power consumption details. If the comparison identifies variances between the actual and expected data, then a security threat is flagged and threat responses are performed.

Abstract: An approach is provided that receives a set of actual hardware power consumption details and a set of software activity details with all of the details pertaining to the use of a computer system at a first time. Based on the set of software activity details, the approach determines a set of expected hardware power consumption details. The set of actual hardware power consumption details are compared to the set of expected hardware power consumption details. If the comparison identifies variances between the actual and expected data, then a security threat is flagged and threat responses are performed.

Abstract: An example embodiment may include a system and method for correcting luminance disturbances in an imaging device. The example method can detect a luminance level disturbance in the output of an imager and provide a signal to a digital signal processor (DSP) that a luminance disturbance was detected, before the DSP begins processing the output of the imager. The DSP can then correct or adjust the resulting output to compensate for the luminance disturbance.

Abstract: An example embodiment may include a system and method for correcting luminance disturbances in an imaging device. The example method can detect a luminance level disturbance in the output of an imager and provide a signal to a digital signal processor (DSP) that a luminance disturbance was detected, before the DSP begins processing the output of the imager. The DSP can then correct or adjust the resulting output to compensate for the luminance disturbance.

Abstract: An alarm system notification device includes a strobe, a communication port, a manual selector that allows manual selection of strobe intensity, and a communication port through which the device transmits an indication of a selected strobe intensity. The device may also include a commandable selector that selects a strobe intensity in response to a command received from the communication port.

Abstract: An alarm system notification device includes a strobe, a communication port, a manual selector that allows manual selection of strobe intensity, and a communication port through which the device transmits an indication of a selected strobe intensity. The device may also include a commandable selector that selects a strobe intensity in response to a command received from the communication port.

Abstract: A method for inhibiting angiogenesis, including: administering a nucleoside, such as tunicamycin, in an amount effective to inhibit angiogenesis, to a patient in need of such treatment. A method for inhibiting angiogenesis, including: administering a nucleoside, which comprises glucosamine, in an amount effective to inhibit angiogenesis, to a patient in need of such treatment; wherein the nucleoside is administered for a period of time, subsequently the administration of the nucleoside is suspended for a period of time of at least about 1 week, and subsequently the administration of the nucleoside is resumed.

Abstract: A method for inhibiting angiogenesis, including: administering a nucleoside, such as tunicamycin, in an amount effective to inhibit angiogenesis, to a patient in need of such treatment. A method for inhibiting angiogenesis, including: administering a nucleoside, which comprises glucosamine, in an amount effective to inhibit angiogenesis, to a patient in need of such treatment; wherein the nucleoside is administered for a period of time, subsequently the administration of the nucleoside is suspended for a period of time of at least about 1 week, and subsequently the administration of the nucleoside is resumed.